amrinone has been researched along with dobutamine in 91 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 42 (46.15) | 18.7374 |
1990's | 37 (40.66) | 18.2507 |
2000's | 8 (8.79) | 29.6817 |
2010's | 4 (4.40) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Erhardt, PW | 1 |
Topliss, JG; Yoshida, F | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Reynolds, GW; Richmond, A; Silke, B; Taylor, SH; Verma, SP | 1 |
Bondy, R; Cattran, C; Dupuis, JY; Nathan, HJ; Wynands, JE | 1 |
Donovan, R; Scalea, TM | 1 |
Butterworth, JF; Prielipp, RC; Royster, RL; Tucker, WY; Zaloga, GP | 1 |
Barcones Mingueza, F; Ibarra de la Rosa, I; Martínez Alarcón, J; Pérez Navero, JL; Suanes Cabello, A; Ulloa Santamaría, E; Velasco Jabalquinto, MJ | 1 |
Agrò, C; Costa, P; Gulotta, G; Romano, V; Sansone, A; Sparacia, B | 1 |
Costa, R; De Marino, V; Marino, A | 1 |
Peters, P; Saborowski, F; Schneider, M | 1 |
Drexler, H; Löllgen, H | 1 |
Marcus, RH; Mitha, A; Patel, J; Raw, K; Sareli, P | 1 |
Auffermann, W; Buser, PT; Jasmin, G; Parmley, WW; Wikman-Coffelt, J; Wu, ST | 1 |
Janicki, JS; McElroy, PA; Reddy, HK; Sundram, P; Weber, KT | 1 |
Anderson-Drevs, K; Budny, J | 1 |
Keren, G; LeJemtel, TH; Reis, D; Sonnenblick, EH | 1 |
Midtbo, KA; Reynolds, G; Silke, B; Taylor, SH; Verma, SP | 1 |
Fujigaki, T; Fukui, S; Gotoh, Y; Haseba, S; Miyako, M; Nakamura, H | 1 |
Aïtkaciali, F; Cupa, M; Fosse, JP; Fournier, JL; Hoang, P; Pourriat, JL | 1 |
Firt, P; Málek, I; Vojtísková, J | 1 |
Besse, B; Brulot, N; Clavier, H; Coulaud, JM; Faitg, R; Labrousse, J; Lissac, J; Rezgui, N | 1 |
Davis, D; Fairman, RP; Glauser, FL; Zeilender, S | 1 |
Acar, J; Le Potier, J; Michel, PL; Sergent, J; Vahanian, A | 1 |
Landmann, H; Löwe, H | 1 |
Andersson, KE | 1 |
Dhainaut, JF | 1 |
Uretsky, BF | 1 |
Leier, CV | 1 |
DiSesa, VJ | 1 |
LeJemtel, TH; Mancini, DM; Sonnenblick, EH | 1 |
Imai, H; Imai, S; Matsui, K; Nakahara, H; Nakazawa, M; Takeda, K | 1 |
Ruggie, N | 1 |
Kolesar, JA; Lawless, CE; Reddy, PS; Uretsky, BF; Valdes, AM; Verbalis, JG | 1 |
Casanegra, P; Chamorro, G; Corbalán, R; Illanes, G; Jalil, J; Martínez, A | 1 |
Roberts, R | 1 |
Kindler, M; Kramer, W; Kremer, P; Schlepper, M; Thormann, J | 1 |
Martínez Martínez, A; Salvati, A; Suárez, LD | 1 |
Al Mudhaffar, A; Chemnitius, KH; Hübler, D; Schilling, G | 1 |
Nielsen-Kudsk, F; Vigholt Sørensen, E | 1 |
Gage, J; LeJemtel, TH; Lucido, D; Rutman, H | 1 |
Guimond, JG; Keating, D; Matuschak, GM; Meyers, F | 1 |
Hayakawa, H; Katoh, T; Koh, M; Munakata, K; Nejima, J; Seino, Y; Shimai, S; Takada, K; Takano, T; Tanaka, K | 1 |
Seino, Y; Takano, T; Tanaka, K | 1 |
Geraets, DR | 1 |
Applefeld, MM | 1 |
Brown, L; Erdmann, E | 1 |
Alpert, JS; Benotti, JR; McCue, JE | 1 |
Janicki, JS; Maskin, CS; Weber, KT | 1 |
Sharpe, DN | 1 |
Hosokawa, T; Kojima, M; Mori, T; Yabuuchi, Y; Yamashita, S | 1 |
Méndez, R | 1 |
Boncyk, J; Redon, D; Rusy, B | 1 |
Hashimoto, K; Mori, T; Yabuuchi, Y; Yamashita, S | 1 |
Hermiller, JB; Leier, CV; Leithe, ME; Magorien, RD; Unverferth, DV | 1 |
Andrews, V; Janicki, JS; Weber, KT | 1 |
Frishman, WH; Klein, NA; LeJemtel, TH; Siskind, SJ; Sonnenblick, EH | 1 |
Alonso Francia, C; Calvo Cebollero, I; Diarte de Miguel, JA; Gomollón García, JP; Placer Peralta, LJ | 1 |
Dodam, JR; Gengo, PJ; Hellyer, PW; Jones, JL | 1 |
Ishikawa, M; Itoh, S; Koga, K; Mori, T; Tominaga, M; Yabuuchi, Y | 1 |
Buser, PT; Jasmin, G; Parmley, WW; Wikman-Coffelt, J; Wu, SY | 1 |
Barbarash, R; Beckham, V; Coulter, L; Davila-Roman, VG; Kurz, H; Morello, PJ; Rich, MW; Sperry, J; Spinner, L; Woods, WL | 1 |
Dagher, E; Dumont, L | 1 |
Crystal, GJ; Kim, SJ; Rock, MH; Salem, MR | 1 |
Ohizumi, Y | 1 |
Berman, K; Fahey, AL; Isom, OW; Ko, W; Krieger, KH; Lang, D; Zelano, JA | 1 |
Biocina, B; Husedzinović, I; Ivancan, V; Nikić, N; Rudeź, I; Rumboldt, Z; Sutlić, Z | 1 |
Clark, WA; Denes, P; Fernandez, RN; Heaney, L; Marius-Nunez, AL; Ranganini, A; Silber, E | 1 |
Arnaudov, D; Cohen, AJ; Ezra, S; Hauptman, E; Sasson, L; Schachner, A; Zabeeda, D | 1 |
Layish, DT; Tapson, VF | 1 |
Himeno, E; Kuroiwa, A; Nakashima, Y; Okazaki, M; Sonoda, S; Takeuchi, M; Tanaka, S | 1 |
Iskandrian, AE | 1 |
Ansley, DM; Dolman, J; Jenkins, IR; O'Connor, JP | 1 |
Geshi, E; Itoh, S; Katagiri, T; Konno, N; Mukae, S; Tomita, M; Umetsu, K; Yanagishita, T | 1 |
Butterworth, JF; Hammon, JW; Legault, C; Royster, RL | 1 |
McCloskey, WW | 1 |
Cocozza, M; De Vecchis, R; Imperatore, F; Nocerino, L; Pucciarelli, G; Setaro, A; Torre, G | 1 |
Dennehy, KC; Dupuis, JY; Nathan, HJ; Wynands, JE | 1 |
Bruhn, A; Bugedo, G; Castillo, L; Dagnino, J; Gigoux, J; Hernández, G; Tomicic, V | 1 |
Goto, F; Isa, Y; Ishikawa, S; Koyama, H; Kunimoto, F; Ohki, S; Tsukagoshi, H; Yoshikawa, D | 1 |
González, F | 1 |
Alam, S; Crystal, GJ; Hu, G; Piotrowski, A; Zhou, X | 1 |
Drago, A; Gómez-Alvis, A; Grassi, A; Milesi, V; Raingo, J; Rebolledo, A; Rinaldi, G; Sanz, N; Tommasi, J | 1 |
Mochizuki, M; Nishimura, R; Sasaki, N; Takao, K; Tobata, D | 1 |
Bae, HB; Jeong, CW; Kim, H; Lee, J; Park, HC; Yoo, KY | 1 |
Komamura, K; Matsuo, H; Sasaki, T | 1 |
Crystal, GJ; Salem, MR; Silver, JM | 1 |
14 review(s) available for amrinone and dobutamine
Article | Year |
---|---|
In search of the digitalis replacement.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Cardiotonic Agents; Cyclic AMP; Digitalis Glycosides; Heart Failure; Humans; Myocardial Contraction; Receptors, Adrenergic, beta; Structure-Activity Relationship | 1987 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Physiological bases and therapeutic uses of inodilator drugs].
Topics: Amrinone; Cardiotonic Agents; Deoxyepinephrine; Dobutamine; Dopamine; Heart Failure; Humans; Milrinone; Phosphodiesterase Inhibitors; Pyridones; Sympathomimetics; Vasodilator Agents | 1991 |
Use of inotropes in the critical care setting.
Topics: Amrinone; Cardiotonic Agents; Dobutamine; Dopamine; Enoximone; Epinephrine; Humans; Imidazoles; Milrinone; Norepinephrine; Phosphodiesterase Inhibitors; Pyridones; Stimulation, Chemical | 1990 |
The role of novel inotropic agents in the treatment of heart failure.
Topics: Amrinone; Animals; Cardiotonic Agents; Dobutamine; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Milrinone; Myocardial Contraction; Physical Exertion; Pyridazines; Pyridones; Time Factors | 1986 |
Some new positive inotropic agents.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Aminopyridines; Amrinone; Cardiotonic Agents; Dobutamine; Dopamine; Drug Tolerance; Enoximone; Heart Failure; Humans; Imidazoles; Milrinone; Phosphodiesterase Inhibitors; Practolol; Prenalterol; Pyridones | 1986 |
The rational selection of inotropic drugs in cardiac surgery.
Topics: Amrinone; Animals; Calcium; Cardiac Surgical Procedures; Cardiotonic Agents; Dobutamine; Dopamine; Epinephrine; Humans; Isoproterenol | 1987 |
Congestive heart failure.
Topics: Aminopyridines; Amrinone; Angiotensin-Converting Enzyme Inhibitors; Cardiac Glycosides; Cardiotonic Agents; Diuretics; Dobutamine; Dopamine; Heart Failure; Humans; Hydralazine; Milrinone; Nitrates; Nitroprusside; Prazosin; Pyridones; Sympathomimetics; Vasodilator Agents | 1986 |
Newer inotropic agents.
Topics: Aminopyridines; Amrinone; Cardiotonic Agents; Dobutamine; Ethanolamines; Heart Failure; Humans; Practolol; Prenalterol; Receptors, Adrenergic, beta | 1984 |
[The old digitalis and the new cardiac inotropic agents].
Topics: Aminopyridines; Amrinone; Arrhythmias, Cardiac; Cardenolides; Cardiotonic Agents; Digitalis Glycosides; Dobutamine; Dopamine; Drug Evaluation; Ethanolamines; Humans; Imidazoles | 1983 |
[Therapeutic options in cardiogenic shock].
Topics: Amrinone; Angioplasty, Balloon, Coronary; Assisted Circulation; Cardiotonic Agents; Coronary Artery Bypass; Dobutamine; Dopamine; Humans; Milrinone; Myocardial Infarction; Nitroglycerin; Phosphodiesterase Inhibitors; Pyridones; Shock, Cardiogenic; Thrombolytic Therapy; Vasodilator Agents | 1995 |
[Tendency of development on novel type of cardiotonic drugs].
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adrenergic beta-Agonists; Amrinone; Animals; Calcium; Catechols; Dobutamine; Dopamine; Fatty Alcohols; Heart Failure; Humans; Pyridazines; Troponin | 1993 |
Pharmacologic hemodynamic support in massive pulmonary embolism.
Topics: Amrinone; Animals; Cardiotonic Agents; Dobutamine; Dopamine; Epinephrine; Hemodynamics; Humans; Isoproterenol; Pulmonary Embolism; Vasoconstrictor Agents; Vasodilator Agents | 1997 |
Use of intravenous inotropic therapy in the home.
Topics: Amrinone; Cardiotonic Agents; Dobutamine; Heart Failure; Home Infusion Therapy; Humans; Infusions, Intravenous; Milrinone; Pyridones | 1998 |
11 trial(s) available for amrinone and dobutamine
Article | Year |
---|---|
Modulation of inotropic therapy by venodilation in acute heart failure: a randomised comparison of four inotropic agents, alone and combined with isosorbide dinitrate.
Topics: Adult; Aged; Amrinone; Cardiotonic Agents; Digoxin; Dobutamine; Heart Failure; Humans; Isosorbide Dinitrate; Male; Middle Aged; Prenalterol; Prospective Studies; Single-Blind Method; Vasodilation | 1992 |
Amrinone and dobutamine as primary treatment of low cardiac output syndrome following coronary artery surgery: a comparison of their effects on hemodynamics and outcome.
Topics: Amrinone; Blood Pressure; Cardiac Output; Cardiac Output, Low; Cardiopulmonary Bypass; Coronary Artery Bypass; Dobutamine; Electrocardiography, Ambulatory; Female; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Oxygen Consumption; Stroke Volume; Syndrome; Treatment Outcome; Vascular Resistance | 1992 |
Calcium inhibits the cardiac stimulating properties of dobutamine but not of amrinone.
Topics: Amrinone; Blood Pressure; Calcium; Cardiac Output; Dobutamine; Double-Blind Method; Female; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Stimulation, Chemical | 1992 |
[The hemodynamic profile of amrinone and enoximone in patients with severe heart failure].
Topics: Aged; Amrinone; Cardiomyopathy, Dilated; Cardiotonic Agents; Coronary Disease; Dobutamine; Dopamine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Infusions, Intravenous; Male; Middle Aged; Phosphodiesterase Inhibitors | 1991 |
Comparison of intravenous amrinone and dobutamine in congestive heart failure due to idiopathic dilated cardiomyopathy.
Topics: Adult; Amrinone; Cardiomyopathy, Dilated; Dobutamine; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Water-Electrolyte Balance | 1990 |
Comparative haemodynamic dose-response effects of dobutamine and amrinone in left ventricular failure complicating acute myocardial infarction.
Topics: Adult; Aged; Amrinone; Dobutamine; Dose-Response Relationship, Drug; Heart; Heart Ventricles; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Random Allocation | 1987 |
[Clinical effects of the infusion of dobutamine and amrinone in patients with refractory cardiac insufficiency].
Topics: Aged; Aged, 80 and over; Amrinone; Body Weight; Clinical Trials as Topic; Dobutamine; Female; Heart Failure; Hemodynamics; Humans; Infusions, Parenteral; Male; Middle Aged | 1987 |
A randomized comparison of intravenous amrinone versus dobutamine in older patients with decompensated congestive heart failure.
Topics: Aged; Aged, 80 and over; Amrinone; Analysis of Variance; Dobutamine; Double-Blind Method; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Prospective Studies; Treatment Outcome; Ventricular Function, Left | 1995 |
Amrinone versus dobutamine in cardiac surgical patients with severe pulmonary hypertension after cardiopulmonary bypass: a prospective, randomized double-blinded trial.
Topics: Amrinone; Cardiopulmonary Bypass; Cardiotonic Agents; Dobutamine; Double-Blind Method; Female; Heart Valve Diseases; Heart Valve Prosthesis; Hemodynamics; Humans; Hypertension, Pulmonary; Male; Middle Aged; Mitral Valve; Phosphodiesterase Inhibitors; Postoperative Period; Prospective Studies | 1997 |
Factors that predict the use of positive inotropic drug support after cardiac valve surgery.
Topics: Amrinone; Cardiotonic Agents; Dobutamine; Double-Blind Method; Epinephrine; Female; Heart Valves; Humans; Male; Multivariate Analysis; Myocardial Contraction; Outcome Assessment, Health Care; Time Factors | 1998 |
[Acute effect of dobutamine and amrinone on hemodynamics and splanchnic perfusion in septic shock patients].
Topics: Acidosis, Lactic; Aged; Aged, 80 and over; Amrinone; Cardiotonic Agents; Dobutamine; Female; Hemodynamics; Humans; Male; Middle Aged; Prospective Studies; Shock, Septic; Splanchnic Circulation; Vasodilator Agents | 1999 |
66 other study(ies) available for amrinone and dobutamine
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Amrinone as an inotrope in managing hypermetabolic surgical stress.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amrinone; Dobutamine; Drug Evaluation; Female; Hemodynamics; Humans; Male; Middle Aged; Myocardial Contraction; Oxygen Consumption; Postoperative Complications; Stress, Physiological | 1992 |
[Combined use of amrinone and dobutamine in the postoperative period following cardiovascular surgery].
Topics: Amrinone; Cardiac Surgical Procedures; Coronary Vessel Anomalies; Dobutamine; Drug Therapy, Combination; Female; Humans; Infant; Postoperative Care | 1991 |
[Mixed venous oxygen saturation as optimization of the therapeutic response in low output syndrome].
Topics: Aged; Amrinone; Cardiac Output, Low; Dobutamine; Female; Humans; Male; Oximetry; Oxygen; Syndrome; Veins | 1991 |
Dobutamine potentiates amrinone's beneficial effects in moderate but not in advanced heart failure. 31P-MRS in isolated hamster hearts.
Topics: Amrinone; Animals; Cardiac Output, Low; Cardiomyopathies; Cricetinae; Dobutamine; Drug Combinations; Drug Synergism; Heart; In Vitro Techniques; Magnetic Resonance Spectroscopy; Mesocricetus; Phosphorus | 1990 |
Myocardial energetics and efficiency in patients with idiopathic cardiomyopathy: response to dobutamine and amrinone.
Topics: Amrinone; Cardiomyopathy, Dilated; Dobutamine; Drug Therapy, Combination; Hemodynamics; Humans; Lactates; Lactic Acid; Male; Middle Aged; Myocardial Contraction; Myocardium; Oxygen Consumption; Thermodilution | 1990 |
IV inotropic agents: dopamine, dobutamine, and amrinone.
Topics: Amrinone; Cardiac Output, Low; Critical Care; Dobutamine; Dopamine; Humans; Infusions, Intravenous | 1990 |
Comparison of the effects of amrinone and dobutamine on hemodynamics and myocardial oxygen balance in dogs with experimental left ventricular failure.
Topics: Amrinone; Animals; Blood Pressure; Cardiac Output, Low; Coronary Circulation; Coronary Disease; Dobutamine; Dogs; Heart; Heart Rate; Hemodynamics; Infusions, Intravenous; Myocardium; Oxygen Consumption; Pulmonary Artery; Pulmonary Wedge Pressure; Stroke Volume; Vascular Resistance; Ventricular Fibrillation; Ventricular Function, Left | 1989 |
[Severe cardiac decompensation: value in the early hours of a combination of amrinone and dobutamine].
Topics: Aged; Aged, 80 and over; Amrinone; Dobutamine; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Contraction; Stimulation, Chemical | 1989 |
[Successful use of amrinone in combination with dobutamine in the treatment of severe heart failure].
Topics: Amrinone; Cardiomyopathy, Dilated; Dobutamine; Drug Therapy, Combination; Humans; Male; Middle Aged | 1989 |
[Hemodynamic effects of amrinone and comparison with dobutamine in patients with chronic respiratory insufficiency with pulmonary hypertension].
Topics: Aged; Amrinone; Dobutamine; Female; Hemodynamics; Humans; Hypertension, Pulmonary; Lung Diseases, Obstructive; Male; Middle Aged | 1989 |
Inotropic and vasoactive drug treatment of interleukin 2 induced hypotension in sheep.
Topics: Amrinone; Animals; Blood Pressure; Calcium Chloride; Cardiac Output; Dobutamine; Dopamine; Heart Rate; Hemodynamics; Interleukin-2; Methoxamine; Recombinant Proteins; Sheep; Stroke Volume; Vascular Resistance | 1989 |
[Positive inotropic agents. Generalities and classification].
Topics: Adrenergic beta-Agonists; Aminopyridines; Amrinone; Calcium; Cardiotonic Agents; Digitalis Glycosides; Dobutamine; Ethanolamines; Heart Failure; Heart Ventricles; Humans; Myocardial Contraction; Phosphodiesterase Inhibitors; Practolol; Prenalterol | 1985 |
[Non-glycoside cardiotonic agents].
Topics: Adrenergic beta-Agonists; Aminopyridines; Amrinone; Blood Pressure; Cardiotonic Agents; Cyclic AMP; Dobutamine; Heart; Hemodynamics; Humans; Phosphodiesterase Inhibitors; Vasodilator Agents | 1986 |
[Use of new inotropic agents in the treatment of acute cardiac failure].
Topics: Adrenergic Agonists; Amrinone; Calcium Channel Blockers; Cardiotonic Agents; Dobutamine; Dopamine; Enoximone; Heart Failure; Humans; Imidazoles; Milrinone; Myocardial Contraction; Pyridones | 1988 |
Is inotropic therapy appropriate for patients with chronic congestive heart failure? Or is the digitalis leaf withering?
Topics: Amrinone; Cardiotonic Agents; Digoxin; Dobutamine; Enoximone; Ethanolamines; Heart; Heart Failure; Heart Function Tests; Hemodynamics; Humans; Imidazoles | 1986 |
General overview and update of positive inotropic therapy.
Topics: Amrinone; Blood Pressure; Cardiotonic Agents; Digitoxin; Dobutamine; Dopamine; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Isoproterenol; Milrinone; Norepinephrine; Phosphodiesterase Inhibitors; Pyridones; Stroke Volume; Time Factors | 1986 |
New positive inotropic drugs for the treatment of congestive heart failure.
Topics: Aminopyridines; Amrinone; Cardiac Output; Cardiotonic Agents; Dipeptides; Dobutamine; Enalapril; Heart Failure; Humans; Milrinone; Myocardial Contraction; Pyridones; Stimulation, Chemical; Vascular Resistance; Vasodilator Agents | 1985 |
Cardiotonic and coronary vasodilatatory effects of amrinone in the canine heart-lung preparation with a support dog as compared with those of dobutamine.
Topics: Aminopyridines; Amrinone; Animals; Cardiotonic Agents; Coronary Circulation; Cyclic AMP; Dobutamine; Dogs; Dose-Response Relationship, Drug; Female; Heart Rate; In Vitro Techniques; Male; Myocardial Contraction; Papillary Muscles; Vasodilator Agents | 1986 |
Combined therapy with dobutamine and amrinone in severe heart failure. Improved hemodynamics and increased activation of the renin-angiotensin system with combined intravenous therapy.
Topics: Adult; Amrinone; Arginine Vasopressin; Dobutamine; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Norepinephrine; Renin; Renin-Angiotensin System | 1987 |
Inotropic therapy for cardiac failure associated with acute myocardial infarction.
Topics: Amrinone; Cardiotonic Agents; Digoxin; Diuretics; Dobutamine; Dopamine; Heart Failure; Humans; Myocardial Infarction; Vasodilator Agents | 1988 |
[Determination of active components of amrinone by analysis of pressure-volume results; use of the conductance (volume) catheter technic and rapid load change by balloon occlusion of the inferior vena cava].
Topics: Amrinone; Cardiac Catheterization; Cardiac Output, Low; Cardiomyopathy, Dilated; Dobutamine; Drug Therapy, Combination; Heart Failure; Hemodynamics; Humans; Myocardial Contraction; Myocardium; Nitroprusside; Oxygen Consumption | 1987 |
[Combination of different inotropic agents in the treatment of chronic refractory cardiac insufficiency].
Topics: Amrinone; Dobutamine; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged | 1987 |
[Comparison of the cardiovascular actions of Cordemcura, isoprenaline and dobutamine in cats].
Topics: Aminopyridines; Amrinone; Animals; Cardiotonic Agents; Cats; Dobutamine; Dose-Response Relationship, Drug; Hemodynamics; Isoproterenol | 1986 |
Myocardial pharmacodynamics of dopamine, dobutamine, amrinone and isoprenaline compared in the isolated rabbit heart.
Topics: Aminopyridines; Amrinone; Animals; Coronary Circulation; Dobutamine; Dopamine; Female; Heart; Heart Rate; In Vitro Techniques; Isoproterenol; Male; Myocardial Contraction; Myocardium; Oxygen Consumption; Rabbits | 1986 |
Additive effects of dobutamine and amrinone on myocardial contractility and ventricular performance in patients with severe heart failure.
Topics: Adult; Aged; Aminopyridines; Amrinone; Blood Pressure; Dobutamine; Drug Synergism; Female; Heart Failure; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Contraction; Stroke Volume | 1986 |
Augmentation of cardiac function in end-stage heart failure by combined use of dobutamine and amrinone.
Topics: Aminopyridines; Amrinone; Arrhythmias, Cardiac; Cardiomyopathy, Dilated; Cardiotonic Agents; Dobutamine; Drug Therapy, Combination; Hemodynamics; Humans; Male; Middle Aged | 1986 |
[Effects of intravenous amrinone (Win 40680) on heart failure complicated by acute myocardial infarction: comparative study with dopamine and dobutamine].
Topics: Aged; Amrinone; Dobutamine; Dopamine; Female; Heart Failure; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction | 1986 |
Effects of intravenous amrinone on heart failure complicated by acute myocardial infarction: comparative study with dopamine and dobutamine.
Topics: Aged; Amrinone; Dobutamine; Dopamine; Female; Heart Failure; Hemodynamics; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction | 1986 |
Drug therapy for congestive heart failure.
Topics: Amrinone; Dobutamine; Heart Failure; Humans | 1986 |
Chronic congestive heart failure. Where have we been? Where are we heading?
Topics: Aminopyridines; Amrinone; Biopsy; Calcium Channel Blockers; Cardiology; Chronic Disease; Digitalis; Dobutamine; Dopamine; Forecasting; Heart Failure; Hemodynamics; Humans; Infusions, Parenteral; Myocardial Contraction; Myocardium; Plants, Medicinal; Plants, Toxic; Prognosis; Quality of Life; Vasodilator Agents | 1986 |
Concentration-response curves of positive inotropic agents before and after ouabain pretreatment.
Topics: Aminopyridines; Amrinone; Animals; Cardiotonic Agents; Cats; Dobutamine; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; Female; Guinea Pigs; Histamine; Imidazoles; In Vitro Techniques; Male; Metaproterenol; Myocardial Contraction; Ouabain; Papillary Muscles; Phenylephrine; Stimulation, Chemical; Theophylline | 1985 |
Comparative vasoactive therapy for heart failure.
Topics: Adult; Aged; Aminopyridines; Amrinone; Arrhythmias, Cardiac; Blood Pressure; Cardiac Output; Cardiotonic Agents; Catecholamines; Dobutamine; Dopamine; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Pulmonary Wedge Pressure; Tachycardia; Vascular Resistance | 1985 |
Pathophysiology of cardiac failure.
Topics: Aminopyridines; Amrinone; Blood Pressure; Cardiac Output; Cardiotonic Agents; Dobutamine; Dopamine; Furosemide; Heart; Heart Failure; Humans; Myocardial Contraction; Nitroprusside; Norepinephrine; Oxygen Consumption; Vascular Resistance; Vasoconstriction | 1985 |
In vitro and in vivo studies of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212), a novel positive inotropic drug, in various animals.
Topics: Aminopyridines; Amrinone; Animals; Blood Pressure; Cardiotonic Agents; Cardiovascular System; Cats; Dobutamine; Dogs; Female; Guinea Pigs; Heart Rate; In Vitro Techniques; Male; Myocardial Contraction; Phentolamine; Pindolol; Pyrazines; Quinolines; Rabbits; Rats; Sodium-Potassium-Exchanging ATPase; Theophylline | 1984 |
Hemodynamic effects of amrinone in dogs anesthetized with halothane: comparison with isoproterenol and dobutamine.
Topics: Aminopyridines; Amrinone; Anesthesia, Inhalation; Animals; Blood Pressure; Cardiac Output; Cardiotonic Agents; Catecholamines; Dobutamine; Dogs; Female; Halothane; Hemodynamics; Infusions, Parenteral; Isoproterenol; Male; Pulmonary Artery; Vascular Resistance | 1984 |
Positive inotropic effect of 3, 4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-qu inolinone (OPC-8212) in the dog with experimentally-induced right-sided heart failure.
Topics: Administration, Oral; Aminopyridines; Amrinone; Animals; Blood Pressure; Cardiotonic Agents; Dobutamine; Dogs; Dose-Response Relationship, Drug; Heart Failure; Heart Rate; Injections, Intravenous; Male; Myocardial Contraction; Pyrazines; Quinolines | 1984 |
Amrinone in severe congestive heart failure: another look at an intriguing new cardioactive drug.
Topics: Adult; Aged; Aminopyridines; Amrinone; Blood Pressure; Cardiac Output; Cardiotonic Agents; Dobutamine; Dose-Response Relationship, Drug; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Stroke Volume; Time Factors; Vascular Resistance | 1984 |
Cardiotonic agents in the management of chronic cardiac failure.
Topics: Adult; Aged; Aminopyridines; Amrinone; Blood Pressure; Cardiac Output; Cardiotonic Agents; Dobutamine; Ethanolamines; Exercise Test; Female; Heart Failure; Heart Rate; Humans; Kidney Function Tests; Male; Middle Aged; Oxygen Consumption | 1982 |
Hemodynamic comparison of intravenous amrinone and dobutamine in patients with chronic congestive heart failure.
Topics: Adolescent; Adult; Aged; Aminopyridines; Amrinone; Cardiac Output; Catecholamines; Chronic Disease; Dobutamine; Female; Heart Failure; Hemodynamics; Humans; Injections, Intravenous; Male; Middle Aged; Pulmonary Wedge Pressure; Time Factors | 1981 |
Amrinone combined with dobutamine improves hemodynamics and oxygen delivery without down-regulation of cardiac beta-adrenergic receptor density in porcine endotoxemia.
Topics: Amrinone; Animals; Disease Models, Animal; Dobutamine; Down-Regulation; Drug Therapy, Combination; Hemodynamics; Hydrogen-Ion Concentration; Oxygen Consumption; Radioligand Assay; Receptors, Adrenergic, beta; Shock, Septic; Sodium Bicarbonate; Swine; Ventricular Function, Right | 1995 |
Differential effects of OPC-18790, amrinone and dobutamine on cardiac function and energy metabolism in the guinea-pig isolated ischaemic heart.
Topics: Adenosine Triphosphate; Amrinone; Animals; Cardiac Pacing, Artificial; Cardiotonic Agents; Coronary Circulation; Dobutamine; Energy Metabolism; Guinea Pigs; Heart; Heart Rate; In Vitro Techniques; Magnetic Resonance Spectroscopy; Male; Myocardial Contraction; Myocardial Ischemia; Phosphocreatine; Quinolones; Ventricular Function, Left | 1995 |
Distinct modulation of myocardial performance, energy metabolism, and [Ca2+]i transients by positive inotropic drugs in normal and severely failing hamster hearts.
Topics: Amrinone; Animals; Blood Pressure; Bucladesine; Calcium; Cardiomyopathies; Cardiotonic Agents; Cricetinae; Digoxin; Disease Models, Animal; Dobutamine; Energy Metabolism; Heart Failure; Isoproterenol; Magnetic Resonance Spectroscopy; Mesocricetus; Myocardial Contraction; Oxygen Consumption; Phosphates; Phosphorylation | 1995 |
Effects of amrinone and dobutamine on PGF2 alpha-induced pulmonary hypertension in dogs.
Topics: Amrinone; Animals; Dinoprost; Disease Models, Animal; Dobutamine; Dogs; Drug Therapy, Combination; Hemodynamics; Hypertension, Pulmonary; Respiratory Function Tests | 1994 |
Effect of intracoronary infusions of amrinone and dobutamine on segment shortening, blood flow, and oxygen consumption in in situ canine hearts.
Topics: Amrinone; Animals; Coronary Circulation; Coronary Vessels; Dobutamine; Dogs; Dose-Response Relationship, Drug; Drug Synergism; Electrocardiography; Female; Heart; Infusions, Intra-Arterial; Male; Myocardial Contraction; Myocardium; Oxygen Consumption | 1994 |
The effects of amrinone versus dobutamine on myocardial mechanics and energetics after hypothermic global ischemia.
Topics: Amrinone; Animals; Coronary Vessels; Dobutamine; Dogs; Hypothermia, Induced; In Vitro Techniques; Myocardial Contraction; Myocardial Ischemia; Myocardium; Oxygen Consumption; Stimulation, Chemical; Vascular Resistance; Ventricular Function, Left | 1993 |
[Hemodynamic effects of amrinone, dobutamine and dopamine in the cardiac low output syndrome following open-heart surgery].
Topics: Adult; Aged; Aged, 80 and over; Amrinone; Cardiac Output; Cardiac Output, Low; Cardiac Surgical Procedures; Cardiotonic Agents; Dobutamine; Dopamine; Female; Hemodynamics; Humans; Male; Middle Aged; Pulmonary Wedge Pressure | 1995 |
Intermittent inotropic therapy in an outpatient setting: a cost-effective therapeutic modality in patients with refractory heart failure.
Topics: Ambulatory Care; Amrinone; Cardiotonic Agents; Cost-Benefit Analysis; Dobutamine; Drug Administration Schedule; Emergency Service, Hospital; Female; Follow-Up Studies; Heart Failure; Humans; Infusions, Intravenous; Length of Stay; Male; Middle Aged; Milrinone; Patient Admission; Patient Education as Topic; Pyridones; Time Factors | 1996 |
Effect of systemic vasodilators on internal mammary flow during coronary bypass grafting.
Topics: Amrinone; Blood Flow Velocity; Blood Pressure; Cardiac Output; Coronary Artery Bypass; Dobutamine; Dopamine; Heart Rate; Humans; Mammary Arteries; Nitroglycerin; Nitroprusside; Vasodilator Agents | 1996 |
Comparative effects of dobutamine and amrinone on coronary blood flow in patients with idiopathic dilated cardiomyopathy.
Topics: Adult; Aged; Amrinone; Cardiomyopathy, Dilated; Cardiotonic Agents; Coronary Circulation; Dobutamine; Female; Humans; Laser-Doppler Flowmetry; Male; Middle Aged | 1997 |
Coronary blood flow in patients with idiopathic dilated cardiomyopathy.
Topics: Amrinone; Cardiomyopathy, Dilated; Cardiotonic Agents; Coronary Circulation; Dobutamine; Humans | 1997 |
The effects of dopamine, dobutamine and amrinone on mitochondrial function in cardiogenic shock.
Topics: Adenosine Triphosphatases; Amrinone; Animals; Cardiotonic Agents; Carrier Proteins; Dobutamine; Dogs; Dopamine; Electron Transport Complex I; Electron Transport Complex IV; Energy Metabolism; Membrane Proteins; Mitochondria, Heart; Mitochondrial Proton-Translocating ATPases; Myocardial Infarction; NADH, NADPH Oxidoreductases; Shock, Cardiogenic; Ventricular Function, Left | 1997 |
[The dobutamine-dopamine combination versus amrinone in congestive heart failure with a marked edematogenic sign complicated by functional kidney failure. A comparison between 2 different models of inotropic stimulation and diuresis potentiation].
Topics: Aged; Amrinone; Cardiotonic Agents; Diuresis; Dobutamine; Dopamine; Drug Evaluation; Drug Therapy, Combination; Edema, Cardiac; Female; Heart Failure; Humans; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Contraction; Prospective Studies | 1998 |
Profound hypoxemia during treatment of low cardiac output after cardiopulmonary bypass.
Topics: Amrinone; Cardiac Output; Cardiac Output, Low; Cardiopulmonary Bypass; Cardiotonic Agents; Dobutamine; Heart Valve Prosthesis Implantation; Humans; Hypoxia; Lung Diseases, Obstructive; Male; Middle Aged; Mitral Valve Insufficiency; Nitroprusside; Oxygen; Positive-Pressure Respiration; Vasodilator Agents | 1999 |
Comparison of the hemodynamic effects of amrinone in patients who required low-to-moderate-dose and high-dose catecholamines after cardiac valve replacement.
Topics: Adult; Aged; Amrinone; Analysis of Variance; Cardiotonic Agents; Catheterization, Swan-Ganz; Dobutamine; Dopamine; Dose-Response Relationship, Drug; Female; Heart Valve Prosthesis Implantation; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Muscle Contraction; Postoperative Period; Prospective Studies | 1999 |
[Dobutamine and amrinone in septic shock patients].
Topics: Amrinone; Cardiotonic Agents; Dobutamine; Humans; Shock, Septic | 1999 |
Lack of role for nitric oxide in cholinergic modulation of myocardial contractility in vivo.
Topics: Acetylcholine; Adrenergic beta-Agonists; Amrinone; Animals; Cardiac Pacing, Artificial; Cardiotonic Agents; Coronary Circulation; Dobutamine; Dogs; Echocardiography; Electric Stimulation; Enzyme Inhibitors; Myocardial Contraction; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Vagus Nerve | 2001 |
Cardiac and vascular effects of diltiazem, dobutamine and amrinone, drugs used after myocardial revascularization.
Topics: Amrinone; Animals; Aorta; Cardiotonic Agents; Diltiazem; Dobutamine; Female; Heart Atria; Humans; Male; Mammary Arteries; Myocardial Revascularization; Rats; Rats, Sprague-Dawley; Saphenous Vein; Vasodilator Agents | 2004 |
Effects of dopamine, dobutamine, amrinone and milrinone on regional blood flow in isoflurane anesthetized dogs.
Topics: Amrinone; Animals; Blood Pressure; Brain; Cardiotonic Agents; Catecholamines; Coronary Circulation; Digestive System; Dobutamine; Dogs; Dopamine; Eye; Isoflurane; Lung; Microspheres; Milrinone; Muscle, Skeletal; Phosphodiesterase Inhibitors; Regional Blood Flow | 2004 |
Effects of inotropic drugs on mechanical function and oxygen balance in postischemic canine myocardium: comparison of dobutamine, epinephrine, amrinone, and calcium chloride.
Topics: Amrinone; Animals; Calcium Chloride; Cardiotonic Agents; Dobutamine; Dogs; Dose-Response Relationship, Drug; Epinephrine; Female; Male; Myocardial Contraction; Myocardial Stunning; Oxidation-Reduction; Oxygen Consumption; Reperfusion Injury; Treatment Outcome | 2005 |
Comparison of the initial hospitalization costs between the patients treated with dobutamine and the patients treated with amrinone for acute decompensated heart failure in a Japanese institute.
Topics: Aged; Amrinone; Cardiotonic Agents; Chi-Square Distribution; Cost-Benefit Analysis; Dobutamine; Drug Costs; Economics, Pharmaceutical; Female; Heart Failure; Hospital Costs; Humans; Japan; Length of Stay; Male; Statistics, Nonparametric | 2008 |
Mechanisms of increased right and left ventricular oxygen uptake during inotropic stimulation.
Topics: Amrinone; Animals; Cardiotonic Agents; Dobutamine; Dogs; Female; Heart Ventricles; Isoproterenol; Male; Myocardial Contraction; Oxygen Consumption; Stimulation, Chemical; Vasodilator Agents | 2013 |